Researchers have analysed the therapeutic benefits of an antiviral drug, nirmatrelvir, and a class of drugs typically used for bone disorders, bisphosphonates, on the coronavirus. Nirmatrelvir treatment proved effective in preventing severe disease but might impact the host immune system’s ability to combat the virus in future. Meanwhile, bisphosphonates were found to enhance antibody responses to viral antigens, reducing COVID-19 risk and hospitalisation rates.
Cybercriminals pwn 850k+ Americans healthcare data – theregister.com
Cybercriminals pwn 850k+ Americans healthcare data theregister.com
